Skip to content
10-Q

Quarterly Report

Biostar Angel Stem Cell Corp

0001493152-18-016388

← back to feed
Filed
Nov 19, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 14, 2018 10.98M sh
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$141.82K
Cash And Equivalents Q3 2018 · Sep 30, 2018 $360.35K
Stockholders Equity Q3 2018 · Sep 30, 2018 −$164.55K
Stockholders Equity Q3 2018 · Dec 31, 2017 −$3K
Current Liabilities Q3 2018 · Sep 30, 2018 $529.5K
Current Liabilities Q3 2018 · Dec 31, 2017 $3K
Current Assets Q3 2018 · Sep 30, 2018 $364.95K
Total Assets Q3 2018 · Sep 30, 2018 $364.95K
Total Assets Q3 2018 · Dec 31, 2017 $0
Net Income Q3 2018 · Sep 30, 2018 −$109.05K
Net Income Q3 2018 · Sep 30, 2018 −$166.6K
Net Income Q3 2018 · Sep 30, 2017 −$250
Net Income Q3 2018 · Sep 30, 2017 −$3.56K
Operating Income Q3 2018 · Sep 30, 2018 $107.05K
Operating Income Q3 2018 · Sep 30, 2018 $164.6K
Operating Income Q3 2018 · Sep 30, 2017 $250
Operating Income Q3 2018 · Sep 30, 2017 $3.56K